The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs

Virology

Volumn 280, Issue 2, 2001, Pages 243-252

  Mergia, Ayalew ^a   Chari, Soumya ^a   Kolson, Dennis L ^b   Goodenow, Maureen M ^c   Ciccarone, Tina ^a  

^a University of Florida College of Veterinary Medicine   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHYTOHEMAGGLUTININ; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELL TYPE; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; GENE CASSETTE; GENE EXPRESSION; GENE TRANSFER; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; LYMPHOID CELL; MITOSIS INHIBITION; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SIMIAN FOAMY VIRUS; SPUMA VIRUS; VIRUS REPLICATION;

CUCUMBER MOSAIC VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN SPUMARETROVIRUS; MURINAE; MURINE LEUKEMIA VIRUS; RABBIT FIBROMA VIRUS; SIMIAE; SIMIAN FOAMY VIRUS; SIMIAN FOAMY VIRUS TYPE 1;

EID: 0035866325     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0773     Document Type: Article

References (63)

1. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G
2. Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture
3. Cell cycle dependence of foamy retrovirus infection
4. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral brood lymphocytes
5. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells
6. Persistent zoonotic infection of a human with simian foamy virus in the absence of an intact orf-2 accessory gene
7. Lymphocytes as cellular vehicles for gene therapy in mouse and man
8. In vivo expression and survival of gene-modified T lymphocytes in rhesus monkeys
9. Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors
10. Sequences in pol are required for transfer of human foamy virus-based vectors
11. Sites of simian foamy virus persistence in naturally infected African green monkeys: Latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa
12. Host factors and the pathogenesis of HIV-induced disease
13. Spumaviruses: A group of complex retroviruses
14. Characterization of a cis-acting sequence in the Pol region required to transfer human foamy virus vectors
15. Identification of a human population infected with simian foamy viruses
16. Transduction of hematopoietic cells by foamy virus vectors
17. Spumavirinae: Foamy virus group infections. Comparative aspects and diagnosis
18. Lentiviral vectors and gene therapy
19. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells
20. Pathogenesis of human immunodeficiency virus infection
21. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus
22. Human immunodeficiency virus infection of cells arrested in the cell cycle
23. Cell tropism of the simian foamy virus type 1 (SFV-1)
24. Replication and regulation of primate foamy viruses
25. Characterization of provirus clones of simian foamy virus type 1 (SFV-1)
26. Use of retroviral vectors for gene transfer and expression
27. Gene transfer by retroviral vectors occurs only in cells that are actively replicating at the time of infection
28. Human foamy virus reverse transcription that occurs late in the viral replication cycle
29. Further evaluation of soluble CD4 as an anti-HIV type 1 gene therapy: Demonstration of protection of primary human peripheral blood lymphocytes from infection by HIV type 1
30. The basic science of gene therapy
31. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
32. The pCL vector system: Rapid production of helper-free, high-titer, recombinant retroviruses
33. Foamy viruses
34. Gene transfer vectors derived from equine infectious anemia virus
35. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons
36. Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors
37. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors
38. High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments
39. Integration of murine leukemia virus DNA depends on mitosis
40. Foamy virus vectors
41. Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step
42. Replicating foamy virus-based vectors directing high level expression of foreign genes
43. Simian foamy virus isolated from an accidentally infected human individual
44. Efficient infection of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vector
45. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro
46. Infection efficiency of T lymphcytes with amphotropic retroviral vectors is cell cycle dependent
47. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes
48. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes
49. Retroviruses as vectors
50. A review of techniqies and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric analysis
51. Lymphocytes are the major reservoir for foamy viruses in peripheral blood
52. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes
53. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes
54. Foamy retroviruses. A virus in search of a disease
55. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells
56. Improvement of gene transduction efficiency in T lymphocytes using retroviral vectors
57. Cis-acting sequences required for simian foamy virus type 1 (SFV-1) vectors
58. Packaging cell lines for simian foam virus type 1 (SFV-1) vectors
59. Generation of retroviral vector for clinical studies using transient transfection
60. Human foamy virus replication: A pathway distinct from that of retroviruses and hepadnaviruses
61. Evidence that the human foamy virus genome is DNA
62. HIV-1 entry into quiescent lymphocytes: Molecular analysis reveals a labile, latent viral structure